Checkpoint Therapeutics, Inc. (CKPT) Social Stream



Checkpoint Therapeutics, Inc. (CKPT): $1.25

-0.03 (-2.34%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Checkpoint Therapeutics Inc (CKPT) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering CKPT.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-10 4 $20 $16 $17.75 $1.77 902.82%
2022-01-25 4 $26 $16 $20 $1.77 1029.94%
2022-01-26 4 $26 $18 $21 $1.77 1086.44%
2022-03-29 4 $26 $18 $22.5 $1.77 1171.19%

The Trend in the Analyst Price Target


CKPT's average price target has moved up $6.7 over the prior 30 weeks.

CKPT reports an average of 510.14% for its upside potential over the past 50 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-25 1 20 8 15.25 2.83 438.87%
2021-07-17 4 20 8 15.80 2.74 476.64%
2021-08-07 4 20 8 15.80 2.60 507.69%
2021-11-08 4 20 16 17.75 4.45 298.88%
2022-01-27 4 26 18 22.50 2.28 886.84%

CKPT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 4 0 0 0 0 4

The Trend in the Broker Recommendations


CKPT's average broker recommendation rating improved by 0.67 over the prior 13 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CKPT as an investment opportunity.

  • In the context of all US stocks, Checkpoint Therapeutics Inc's upside potential (average analyst target price relative to current price) is greater than 396.22% of them.
  • To contextualize these metrics, consider that out of all US stocks, Checkpoint Therapeutics Inc's number of analysts covering the stock is higher than 76.32% of them.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Checkpoint Therapeutics Inc's variance in analysts' estimates is lower than -18.92% of them.
  • In the context of Healthcare stocks, Checkpoint Therapeutics Inc's average analyst price target is greater than 133.79% of them.

Stocks similar to Checkpoint Therapeutics Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are CINC, CELU, and CDMO.

Is CKPT a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7753 seconds.